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Abstract
Microorganisms colonizing different mucosas can exert 
diverse type of beneficial effects if they are included in 
probiotic formula. Then, the objective of this work was 
to complete the set of probiotic-related characteristics of 
different lactic acid bacteria strains previously isolated 
from different bovine mucosas to further include them in a 
probiotic product. The studies include some complementary 
assays related with their surface-adhesive characteristics 
(autoaggregation, biofilm formation, hydrophobicity, 
production of exopolisaccharides), production of inhibitory 
substances against pathogenic bacteria (hydrogen peroxide, 
bacteriocins). Also, the strains compatibility to go further 
in the design of a multi’strain probiotic formula to be 
used either to pregnant cows through the vaginal tract 
(for metritis prevention), later to the newborn calves (for 
diarrhea prevention), and to the mammary gland of the cows 
(for mastitis prevention). The formula will be integrated by 
strains from the three bovine tracts, being host’ specific and 
able to promote the mucosal colonization and the beneficial 
effect in different ages and physiological states of bovines. 
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Introduction  
The microbiome of different human or animal tracts is con-
stituted by a wide set of microorganisms (bacteria, viruses, ar-
chaea or lower eukaryotes) in ecological balance that inhabit 
a specific environment, such as the gastrointestinal, reproduc-
tive, respiratory tracts, mucous surfaces or other [1,2]. With 
the emergence of sequences based molecular methods that al-
lowed the analysis of complex microbial communities [3], our 
understanding of the key functions that the microbiome plays 
in the illness, health, growth and development of the specific 
host has increased extensively [4]. In such a way that the mi-
crobioma is being currently considered as an organ, since it pro-
vides metabolic activities, coding capabilities and fulfills a wide 
variety of physiological functions that include immunomodula-
tion and prevention of infections in humans and animals, be-
side others [5,6]. Factors such as birth mode, environmental 
conditions and\or genetic polymorphisms, or host-specificity 
determine the bacterial genera presence or its dominance in 
the microbioma, being modified along the time and in many 
situations, indicating also the host-specific dependence [5,7-
11]. Eventhough, different researches have shown remarkable 
similarities in the dominant bacterial species in the tracts and 
mucous membranes of different hosts [12-14]. 
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Referred to the microbiome of bovine tracts, it can be af-
fected by endogenous or exogenous factors, which allow the 
entry and proliferation of pathogenic or potentially pathogenic 
microorganisms that generate infections. Traditionally, antibiot-
ics and antimicrobials are the therapies currently applied; how-
ever, the unintended consequences of their administration as 
residues in meat and milk, and spread of bacterial resistance 
with the risk of vertical transmission to other members of the 
microbiota, have forced to search alternative and innovative 
strategies to reduce the massive use of antibiotics against in-
fectious diseases [15,16,24]. Then, the application of natural 
products demonstrating positive effects was proposed, includ-
ing probiotics, prebiotics, enzymes, natural extracts and organic 
acids. In recent years, probiotics for small ruminants have been 
authorized in the European Union for the first time, both for 
young animals (lambs and kids), adults (sheep and dairy goats), 
and milk buffaloes, since previously only probiotics for cattle 
were authorized [17]. Probiotic microorganisms are defined as 
"viable microorganisms that are administered to the host in ad-
equate quantities to produce a beneficial physiological effect" 
[18-20]. Most of the bacteria used as probiotic in animals are 
lactic acid bacteria (LAB) sustained by their GRAS status (gener-
ally recognized as safe), being Lactobacillus one of the most fre-
quently used supported by the EFSA qualification of this genus 
as QPS (Qualified Presumption of Safety). Referred to their use 
in cattle, different scientists have shown that the application of 
an adequate combination of probiotics could effectively coun-
teract an endometrial infection by E. coli [21-23]. Pellegrino et 
al. [16] showed that the intramammary administration of LAB 
during the drying period in dairy cows stimulates locally and 
systemically the immune system, and could be used as an alter-
native therapy for the treatment and/or prevention of mastitis. 
Maldonado et al [25] demonstrated that oral administration of 
a Lactobacillus mixture decreased the incidence of diarrhea in 
calves, because those of infectious origin are the main causes of 
mortality in calves during the first weeks of life. 
It must be pointed out that the protective effect of LAB can 
be exerted by different mechanisms, including suface-adhesion 
related properties (hydrophobicity, self and co-aggregation), 
production of Exopolysaccharides (EPS), biofilm formation, or 
the capability to produce antagonistic substances (organic acids 
as lactic or acetic, hydrogen peroxide or bacteriocins) to protect 
against pathogens [26]. The enzymes produced by LAB in food 
additives for ruminants are of main interest to catalyze degrada-
tive reactions during digestion, either components of the veg-
etal cell wall they receive (cellulases, xylanases, E-glucanases, 
pectinases, etc.), as well as its content (amylases, proteases). 
The efficient digestion of complex substrates in the rumen re-
quires the combined action of many enzymes, subject of main 
interest when selecting LAB that express some type of hydro-
lytic activity to favor the degradation of the food consumed by 
animals. Some other mechanisms proposed are the competi-
tion for nutrients or the inmunemodulation. 
Our research group have isolated, quantified, identified by 
pheno and genotypic methods different groups of cultivable 
microorganisms from cattle tracts, with special interest in 
lactic bacteria, which are predominant in some of these 
mucosas and historically used as probiotics [27-29,45]. They 
were administered to animals, at the same tract of isolation 
supported by the host and mucose specificity of the lately 
described microbioma [16,24,25,28-33]. Some of the beneficial 
properties were evaluated at that moment by applying the 
Microorganism Origin
Lb. gasseri                      CRL 1461 Bovine vagina*
Lb. delbrueckii               CRL 1460 Bovine vagina*
Lb. gasseri                      CRL 1412 Bovine vagina*
Lb. gasseri                      CRL 1421 Bovine vagina*
Lb. fermentum                CRL 1580 Bovine vagina
Lb. fermentum                CRL 1577 Bovine vagina
Lb. fermentum                CRL 1576 Bovine vagina
Lb. fermentum                CRL 1575 Bovine vagina
Lb. fermentum                CRL 1574 Bovine vagina
Lb. fermentum                CRL 1573 Bovine vagina
Lb. fermentum                CRL 1571 Bovine vagina
Lb. fermentum                CRL 1570 Bovine vagina
Lb. fermentum                CRL 1568 Bovine vagina
Lb. fermentum                CRL 1567 Bovine vagina
Lb. fermentum                CRL 1566 Bovine vagina
Lb. gasseri                     CRL 1556 Bovine vagina
Lb. fermentum                CRL 1557 Bovine vagina
Lb. fermentum                CRL 1558 Bovine vagina
Lb. fermentum                CRL 1559 Bovine vagina
Lb. fermentum                CRL 1560 Bovine vagina
Lb. fermentum                CRL 1561 Bovine vagina
Lb. fermentum                CRL 1562 Bovine vagina
Lb. fermentum                CRL 1563 Bovine vagina
Lb. fermentum                CRL 1564 Bovine vagina
Lb. fermentum                CRL 1565 Bovine vagina
techniques available at the time of isolation.
As we are interested in go further in the design of a probiotic 
formula homologous to the host, to be applied to different 
bovine tracts, the objective of this work is to complement the 
evaluation of the beneficial properties of the strains previously 
selected from different cattle mucose, and the compatibility 
between them, in such a way to have available scientific criteria 
for the next formulation step.
Materials and methods 
Microorganisms and culture conditions
The microorganisms used in this study were selected 
previously by our research group and are shown in Table 1. 
Strains of lactic acid bacteria (LAB) were isolated from different 
bovine ecosystems; vagina and mammary gland of adult cows, 
and oral cavity and gastrointestinal tract of calves, and the first 
set of beneficial characteristics were previously determined 
[26,28,32].
Table 1: Origin of isolation of selected beneficial LAB strains 
evaluated 
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Lb. plantarum                 CRL 1716 Bovine mammary glandγ
Lb. perolens                   CRL 1724 Bovine mammary glandγ
Lc. lactis subsp lactis     CRL 1655 Bovine mammary glandγ
P. pentosaceus              CRL 1831 Bovine mammary glandγ
W. cibaria                      CRL 1833 Bovine mammary glandγ
E. hirae                          CRL 1835 Bovine mammary glandγ
E. hirae                          CRL 1842 Bovine mammary glandγ
E. mundtii                      CRL 1656 Bovine mammary glandγ
E. faecium                     CRL 1657 Bovine mammary glandγ
Lb.  johnsonii                CRL 1693 Faecal matter calves+
Lb. murinus                   CRL 1695 Faecal matter calves+
Lb. mucosae                 CRL 1696 Faecal matter calves+
Lb. amylovorus             CRL 1697 Faecal matter calves
Lb. salivarius                CRL 1702 Faecal matter calves+
E. faecium                    CRL 1703 Oral cavity calves
CRL: Centro de Referencia para Lactobacilos Culture Collection.
*Probiotic properties published by Otero et al (2006).
γ Probiotic properties published by Espeche et al (2012).
+Probiotic properties published by Maldonado et al (2012).
The microorganisms were stored in milk-yeast extract (13% 
non-fast milk, 1% yeast extract) (Britania, Argentine) at -20 °C, 
inoculated at 2% in MRS broth (de Man et al., 1960) (Biokar, 
France) at 37 °C for 24 h, and subcultured twice every 12 h. 
The third subculture was washed with sterile saline (0.85% Na 
Cl), centrifuged (7.000 rpm, 5 min, Presvac, Argentine) and the 
supernatant discarded.
Bacterial surface properties 
Degree of hydrophobicity and auto-aggregation test 
Surface hydrophobicity was evaluated and quantified by de-
termining the variation of optical density at 600 nm (OD600 nm) 
of cell suspensions in physiological solution after partition with 
organic solvents [34] adding xylene and toluene, as modified 
by Ocaña et al [35-37]. The pellet was washed twice with saline 
(0.85% NaCl), centrifuged and resuspended to an OD600 nm= 0.60 
± 0.06 (Spectronic 20, Bausch and Lomb, Rochester, New York, 
USA). The exact value of initial OD600 nm (OD0) was recorded. 0.6 
ml of hydrophobic solvent (xylene and toluene) (Cicarrelli, Ar-
gentine) was added to the tubes with 3.6 ml of bacterial sus-
pension (solvent-bacterial suspension ratio: 1/6). They were 
vortexed for 1 minute and the final OD600nm (ODf) determined 
again after 15 min agitation. The values were recorded as ODf. 
The percentage of hydrophobicity was calculated applying 
the following formula [38]: Eq. 
(A)  % Hydrophobicity: [(OD0 - ODf) / OD0] x 100       (1)
The percentage of hydrophobicity of the strains was classi-
fied as low (0-35%), medium (36% -70%) and high (71-100%).
The autoaggregation was determined applying the tech-
nique described by Vandevoorde et al. [38] and modified by 
Ocaña and Nader Macías [39]. The microorganisms were centri-
fuged and washed three times in saline and the OD600 nm= 0.60 
± 0.05 adjusted (Spectronic 20, Bausch and Lomb, Rochester, 
New York, USA). The suspensions were allowed to settle deter-
mining the OD600nm at different periods of time (1, 2, 3, 4 and 24 
h). The percentage of autoaggregation was calculated applying 
an expression similar to that used to determine the percentage 
of hydrophobicity. The strains autoaggregation was classified as 
low (0-35%), medium (36% -70%) and high (71-100%).
Production of biofilm
To evaluate the ability of the strains to form biofilms, the 
technique of quantification of biofilm in polystyrene mi-
croplates [40-42] modified in the Laboratory was applied [43]. 
The culture media assayed were: A) standard MRS and LAPTg 
broths, and B) MRS and LAPTg broths with individual omis-
sion of Tween 80. Lactic bacteria were subcultured in MRS and 
LAPTg broths as described before. The cell pellets were resus-
pended in 5 ml of the different culture media, adjusted to 1.5 
(OD540nm) corresponding to 2–2,5 x 108 colony forming units per 
milliliter (CFU/ml), and distributed in 200 μl aliquots in polysty-
rene microplates wells (bottom U). They were incubated at 37 
°C under static conditions for 72 h. The quantification of biofilm 
formation was performed after discarding the culture medium 
and washing the wells with 200 μl of phosphate buffered saline 
(PBS: NaCl 8 g/l; KCl 0.0002 g/l; Na2HPO4 1.15 g/l; KH2PO4 0.2 
g/l; pH 7.4). The formed biofilms in the wells were stained with 
0.1% (w/v) Crystal Violet for 30 min at room temperature. Each 
well was washed with 200 μl sterile distilled water to remove 
excess dye. The microplates were left inverted for 14-16 h at 
room temperature. The stained biofilm was eluted with 200 μl 
of 30% glacial acetic acid and incubated 15 min at room temper-
ature, transfering aliquots (135 μl) to a second microplate (flat 
bottom) in which the OD was determined at 570 nm (OD570nm) in 
a microplate spectrophotometer reader (VERSAmax, Molecular 
Devices, Sunnyvale, California, USA).
Production of exopolysaccharides (EPS)
Qualitative determination
The ability of LAB to produce exopolysaccharides was deter-
mined by applying the technique described by Van Geel-Schut-
ten et al. [44]. Strains from different bovine origin (cow repro-
ductive tract, bitch's milk and gastrointestinal tract of calves) 
were seeded by spot (5-6 drops of 10 μl) in de Man, Rogosa and 
Sharpe (MRS) agar media supplemented with high concentra-
tions (100 g/l) of different sugars: glucose, fructose, maltose, 
raffinose, sucrose, galactose or lactose. The plates were incu-
bated at 37 °C for 72-96 h. The EPS producing strains were evi-
denced by observing the appearance of the colonies, collected 
with a sterile spatula and the phenotype (ropy/mucous) charac-
teristic of the EPS produced. 
Quantitative determination of EPS
To determine the amount of EPS produced by LAB in the 
qualitative method, the technique described by Quesada et al. 
[45] was applied. The strains were subcultured three times in 
MRS broth at 37 °C for 24 h, and later three more times in en-
riched media (MRS glucose and MRS sucrose, sugars at 10%), at 
37 °C for 10 h, and the last one at 37 °C for 72 h. The tubes were 
centrifuged at 15,000 rpm for 30 min at 4 °C, and the superna-
tant transferred to sterile bottles in which 2 volumes of 96° (v/v) 
cold ethanol (National Institute of Viticulture, Argentine) were 
added, allowed to settle for 48 h in cold room (4 °C), and cen-
trifuged at 15,000 rpm 60 min at 4 °C. The supernatants were 
discarded and the pellets allowed to dry at room temperature 
and weighed (up to constant weight values) to calculate the 
amount of EPS (in milligrams) produced per gram of LAB and 
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liter of culture medium.
Production of inhibitory substances (organic acids, hydro-
gen peroxide, bacteriocins) of bovine BL against pathogens 
causing bovine infections Qualitative determination of H2O2
To determine the production of hydrogen peroxide, the qual-
itative agar plate method was applied, as described by Juarez 
Tomás et al. [46]. In this method, the peroxidase enzyme (in-
corporated into the agarized medium) catalyzes the oxidation 
of a chromogenic substrate (TMB) in presence of hydrogen per-
oxide. The grown colonies of lactobacilli-H2O2 producer strains 
were colored blue or brown in the presence of oxygen from 
the air. The reagents used were: Solution A: TMB 17.34 mM in 
methanol and solution B: 100 U/ml peroxidase. The final con-
centrations in each plate were: TMB 1mM and peroxidase 2 U/
ml. Each strain of lactobacilli was seeded on the surface of the 
TMB-MRS plates and incubated in microaerophylic conditions 
at 37 °C for 48 h. At the end of the incubation, the plates were 
exposed to the air and coloration of the colonies recorded. The 
production of H2O2 was classified according to the color inten-
sity of the colonies, such as: ++, +, + d (some coloured colonies), 
and - (negative).
Production of inhibitory substances. Agar diffusion meth-
od
To evaluate the inhibitory activity of lactic acid bacteria 
against pathogenic microorganisms, the plate diffusion tech-
nique was used according to Jack et al [47], modified by Ocaña et 
al [48]. The cell-free supernatants were centrifuged and filtered 
and added to pathogens (different concentrations) inoculated 
on soft agar plates. Also the chemical nature of the antagonistic 
substances was determined: the supernatants were neutralized 
with NaOH 2 mol/l (Cicarrelli, Argentine) to define the organ-
ic acid nature. They were later neutralized (pH: 6.5) and then 
treated with catalase 1000 U/ml (Sigma-Aldrich, St Louis, USA) 
to decide if they were oxygen peroxide or bacteriocins.
Referred to the pathogen strains, Triptic Soy Broth (TSB), 
Brain Heart Infusion (BHI) (Britania, Argentine) and Todd Hewitt 
plates (1% agar) were prepared by inoculating 15 μl of active 
pathogenic strains (107 - 109 CFU) in 15 ml of culture medium 
(specific for each microorganism), melted and cooled to 30 °C. 
Once solidified the plates, 6 mm wells were performed in which 
30 μl of supernatants (pure, neutralized and neutralized-treat-
ed with catalase) of LAB under study were seeded. The plates 
were incubated for 3 h at room temperature and subsequently 
at 30 °C for Listeria monocytogenes and at 37 °C for the other 
pathogens for 24-48 h. The size of the diameters of inhibition 
halos was measured in mm.
Enzymatic activities of LAB isolated from the vagina, mam-
mary gland of adult bovine females, and calves faeces.
The screening of production of different type of enzymes, 
some of them related with a specific beneficial characteristic 
was performed in all the strains. To determine amylase activ-
ity, LAB were subcultured in MRS broth. 50 μl of each bacte-
rial suspension was added in wells of MRS-agar starch plates, 
incubated at 37 °C for 48 h. The positive enzymatic activity was 
evidenced by the addition of Lugol, due to the presence of clear 
zones around the wells, indicating the enzymatic degradation 
of the starch. Producer Lb. amylovorus CRL1949 strain (provid-
ed by Laboratory of Plant Technology Ecophysiology, CERELA-
CONICET) was used as positive control.
To evaluate the xylanase activity, LAB suspensions (50 μl) 
were added in wells (6 mm) performed aseptically on MRS-xy-
lan agar plates. They were incubated at 37 °C for 48-72 h. After 
that time, a Congo Red solution added on the plate was used as 
developer, and allowed to act for 15 min. The dye turned the 
xylan to red, then the positive xylanase activity was evidenced 
by the presence of clear zones (halos) around the well, indicat-
ing the enzymatic degradation of the xylan.
To study the production of cellulase activity in LAB, cell sus-
pensions were seeded in wells (50 μl) performed in MRS-car-
boxymethyl cellulose (CMC) agar plate. The plates were incu-
bated at 37 °C for 48-72 h without inverting. Then they were 
stained by adding Congo Red solution to the plate surface and 
allowed to act for 15 min. The dye stains the CMC red, then 
the positive cellulase activity was evidenced by the presence of 
clear zones around the well, indicating the enzymatic degrada-
tion of carboxymethylcellulose.
Compatibility between BL strains
The compatibility between the LAB strains from the three 
tracts under study: vaginal tract and mammary gland of adult 
bovine females, and gastrointestinal tract of calves, was evalu-
ated by the agar plate diffusion method [49]. Each one of the 
microorganisms was used as an indicator and as a producer of 
inhibitory substances. Different LAB concentrations (107 and 
109 CFU/ml) were inoculated into semi-soft LAPTg agar plates 
(1% agar) as indicators microorganism. In the assays of bacteria 
as producers, the treatment of supernatants (with NaOH and 
catalase) was applied to determine the nature of the inhibitory 
substances (organic acids, hydrogen peroxide or bacteriocins) 
as described before. The microorganisms, as producers, were 
activated by successive sub-cultures in MRS broth. The third 
subculture was centrifuged at 6000 rpm for 10 min. Each super-
natant was distributed in three tubes (pure, neutralized with 
NaOH and neutralized-treated with catalase) and pH measured. 
Aliquots (25 μl) of the pure and treated supernatants were add-
ed in the wells of agar plates containing the indicator strains. 
The plates were incubated at room temperature for 5 h, and 
then 24 h at 37 °C.
Statistical analysis




The strains used in this work were selected previously by 
their beneficial characteristics [27,28,50], planning at that time 
their use in each specific homologous tract or ecological sys-
tem and host. But, when planning to go further in the selec-
tion of those strains with higher or more outstanding properties 
to be used as a single formula, some specific techniques and 
complementary studies were required. In this sense, the benefi-
cial strains used to complement the probiotical characteristics 
screening are included in Table 1, being isolated from three dif-
ferent bovine ecosystems.
The evaluation of the surface properties of the strains, re-
lated to their adhesion capability has shown that most of the 
strains from the vaginal tract were not able to autoaggregate. 
The strain with higher index was Lb. gasseri CRL1461 as shown 
in Figure 1. Similar pattern was observed in the autoaggrega-
tion values of the mammary gland strains, most of them with 
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low indexes, except Lb. plantarum CRL1716 with 51% (Table 2). 
Referred to the hydrophobicity capability, most of the strains 
from vagina were non-hydrophobic, being Lb. gasseri CRL1461 
(60%), Lb. delbrueckii CRL1460 (58%), Lb gasseri CRL1421 (64%) 
and CRL1412 (72%) the strains with higher indexes.
Figure 1: Surface characteristics of selected LAB isolated from 
vaginal tract. Self-aggregation and hydrophobicity index (in tolu-
ene and xylene). Facultative heterofermentative (●), obligate het-
erofermentative (X) and obligate homofermentative (♦) strains







Lb. plantarum             CRL 1716 51,95 96,87
Lb. perolens                CRL 1724 5,55 75,09
Lc. lactis subsp lactis CRL 1655 14,37 13,51
P. pentosaceus           CRL 1831 10,00 0,00
W. cibaria                  CRL 1833 8,41 82,91
E. hirae                      CRL 1842 4,69 13,33
aAutoaggregative capability (Ocaña and Nader-Macias, 2002).
bDetermined by MATH in hexadecane (Otero et al, 2004).
In the mammary gland strains, three of the strains: Lb. plan-
tarum CRL1716, Lb. perolens CRL1724 and W. cibaria CRL1833 
showed high hydrophobicity indexes. These results indicate that 
the two characteristics related with the adhesion capability of 
the strains are not directly correlated, or expressed together in 
one strain: in some strains only one of them is expressed, while 
in other strains the other. This type of behavior was also ob-
served in feedlot isolated strains, where some strains showed 
to be autoagregants, while some other were hydrophobic [26]. 
In human host isolated strains, this differential activity was also 
evidenced [51]. 
Biofilm forming strains
The capability to form biofilm is also a characteristic more 
frequently and strongly related to the mucosal adhesion and 
permanence capabilities of the strains under evaluation [43]. 
From the biofilm formed strains, a different behavior was also 
obtained. The vaginal strains showed that some of them were 
able to form biofilm in most of the media assayed. Lb. fermen-
tum CRL1573/1574/1575 and 1576 formed biofilm in LAPTg, 
MRS and MRS without tween 80. Lb. gasseri CRL1412/1421, Lb. 
delbrueckii CRL1460, Lb. fermentum CRL1556/1559/1560/1563 
and 1564 strains formed biofilm only in complete MRS broth, 
while Lb. fermentum CRL1560/1561 and 1564 formed slightly 
lower biofilm in this media without tween added. In LAPTg with 
not tween, most of the strains did not form biofilm, as observed 
in Figure 2a. 
Referred to the mammary gland isolated strains, Lb. plantarum 
CRL1716 showed to form biofilm only in MRS media (Figure 2b).
In the case of calves faeces origin (Figure 2c) the strains did 
not form biofilm in the assayed media.
Figure 2: Formation of biofilms of lactic bacteria strains isolat-
ed from the reproductive tract (a), mammary gland (b) of cows, 
and gastrointestinal tract (c) of lactating calves in MRS and LAPTg 
broths with (0.1%) or without Tween 80. The data are expressed as 
the mean values of OD560nm ± standard error of the biofilms formed 
in microplates stained with crystal violet and solubilized with 
ethanol. The rows with different capital letters indicate significant 
differences (p <0.05) in the formation of biofilms of the different 
strains in the same culture medium. The columns with different 
lowercase letters indicate significant differences (p <0.05) in the 
formation of biofilms of the same strains in different culture media 
according to the Tukey test. Methods are described in the text
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These results indicate that the capability to form biofilm in 
different culture media is again a characteristic of each strain, 
and must be assayed individually in each specific case. These 
results are similar to the ones described by [43], showing 
different behavior of the strains isolated from human vagina in 
different culture media.
Exopolysaccharides production
The production of exopolysaccharides is highly related to 
the formation of a mucous coverage in a way to promote the 
approach of the strains to the animal cells or mucosal surfaces. 
The importance of EPS production in specific strains is also being 
studied more recently, due to the close relationship between 
the EPS production and the immune stimulation. Chabot et al. 
[52] have shown that exopolysaccharides from Lactobacillus 
rhamnosus RW-9595M stimulate TNF, IL-6 and IL-12 in human 
and mouse cultured immunocompetent cells, and IFN- in mouse 
splenocytes, acting as adjuvants or stimulators of the immune 
system. These immunomodulatory polysaccharides exert their 
action through cell membrane receptors whose nature, density 
and cellular distribution contribute to the response. EPS are 
well known as mitogens for a wide variety of cells [53].
From the 17 strains evaluated, only 6 (18%) were able to 
produce EPS (Figure 3a), being 2 of them mucous-EPS, and 4 
ropy-EPS. The quantification of EPS of the 6 producer strains 
in sugar-added media have shown that the amount of EPS is 
different, and depends on the sugar used as main source of 
production. Lb. gasseri CRL1412 and Lb. fermentum CRL1576 
were the strains showing higher EPS production on MRS 
glucose (Figure 3b up). When sucrose was the carbon source, 
Lb. fermentum CRL1580/1576 and W. cibaria CRL1833 were the 
higher EPS producer strains, indicating that this characteristic 
is also related to each specific strain (Figure 3b low). Previous 
studies indicated that the carbon source added to the culture 
media plays an important role in the phenotype and total 
amount of polysaccharide produced. The use of single sugar 
does not promote a higher EPS production in all the strains, 
because it depends on the metabolic capability of the strain 
under assay. Cerning et al. [54] showed that EPS production by 
Lb. casei CG11 in basal medium containing glucose was higher 
than in the same medium with lactose or galactose. Lb. casei 
CRL87 was able to produce 1.7 times more EPS in galactose 
than in glucose, according to Mozzi et al. [55].
Figure 3: Production of exopolysaccharides (EPS) in lactic acid 
bacteria strains isolated from different bovine ecosystems. (a) EPS 
classification according to phenotype, and (b) quantitative deter-
mination in MRS broth (10% glucose added) and MRSs (10% su-
crose added). The rows with different capital letters indicate sig-
nificant differences (p <0.05) in EPS production of different strains 
in the same culture medium tested. The columns with different 
lowercase letters indicate significant differences (p <0.05) in the 
EPS production of the same strain in two culture media tested ac-
cording to the Tukey test
Inhibitory substances production
The assays performed to determine the production of in-
hibitory substances have shown different degree of H2O2 pro-
duction in agar media, according to the oxidized colour of the 
colonies, indicating that all the strains were able to produce 
H2O2. Lb. gasseri CRL1412, Lb. fermentum CRL1575, P. pentosa-
ceus CRL1831, Lb. johnsonii CRL 1693 and Lb. mucosae CRL1696 
strains were the ones showing higher production levels (Table 
3). When looking at the other inhibitory substances produced 
from strains isolated from the three ecosystems, the results 
indicated in Figure 4 were obtained. The strains isolated from 
vagina only were able to inhibit Listeria monocytogenes (shown 
as a photo example in Figure 5), while those isolated from the 
mammary gland and calves faeces have shown a wider spec-
trum of pathogen inhibition. The quantitative determination of 
the size of haloes is indicated in Tables 4a and 4b. The calves’ 
strains showed to inhibit L. monocytogenes, E. faecium, S. dys-
galactiae, S. uberis, S. aureus, S. dublin, S. Tiphymurium, E. coli 
and S. infantis. The mammary gland strains inhibited L. mono-
cytogenes, E. faecium, S. dysgalactiae, S. agalactiae, Staphylo-
coccus coagulase-negative and S. bovis. The inhibitory potential 
of the LAB strains under evaluation indicates that each strain 
shows a specific inhibition pattern that must be assayed when 
studying each particular strain. The ability of various LABs to 
inhibit the growth of pathogenic microorganisms has been 
documented, as well as the antimicrobial activities of cell-free 
supernatants of LAB isolates of different origins. Bacteriocins 
are a group of potent antimicrobial peptides produced by some 
microorganisms, including LAB, active against closely related or-
ganisms, mainly gram-positive bacteria to obtain a competitive 
advantage for nutrients in the environment [56]. The LAB strains 
that produce bacteriocins are protected from their own toxins 
by the expression of a specific immune protein, encoded in the 
bacteriocin operon [57]. LABs isolated from bovine ecosystems 
show various antimicrobial activities, through the production of 
different metabolites, including lactic acid, hydrogen peroxide 
and bacteriocins.
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Figure 4: Production of inhibitory substances by lactic bacteria 
isolated from vagina and mammary gland of adult bovine females 
and feces of lactating calves. The pathogens tested were: L. mono-
cytogenes, E. faecium, S. dysgalactiae, S. uberis, S. aureus, S. aga-
lactiae, SCN, S. bovis, S. dublin, S. tiphymurium, E. coli and S. infan-
tis. The quadrants in different trace correspond to the tracts from 
which the lactic bacteria were isolated. Each rectangle represents 
one of the selected strain
Figure 5: Inhibition of Listeria monocytogenes by neutralized 
supernatants of LAB strains isolated from bovine mammary gland
Table 3: Qualitative determination of hydrogen peroxide pro-
duction by lactic bacteriaa
Strains Hydrogen peroxideb
Lb. gasseri CRL 1412 +++
Lb. gasseri CRL 1421 +
Lb. gasseri  CRL 1460 ++
Lb. delbrueckki CRL 1461 +
Lb. fermentum CRL 1574 ++
Lb. fermentum CRL 1575 +++
Lb. gasseri CRL 1566 ++
Lc. lactis subsp lactis CRL 1655 ++
Lb. plantarum CRL 1716 +
Lb. perolens CRL 1724 +
P. pentosaceus CRL1831 +++
W. cibaria CRL 1833 ++
E. hirae CRL 1842 +
Lb. johnsonii CRL1693 +++
Lb. murinus CRL 1695 ++
Lb. mucosae  CRL 1696 +++
Lb. salivarius CRL 1702 ++
Table 4: Inhibitory activity of LAB isolates from gastrointestinal tract (4a) of suckling calves and mammary gland (4b) of adult 
cows   against pathogens responsible for infections in cattle, using the plate diffusion technique (Inhibitory Halos in mm)
Strain
L. monocytogenes E. coli S. aureus E. faecium
Neut N.N Neut N.N Neut N.N Neut N.N
Lb. johnsonii CRL 1693 0 0 2 0 1 0 0 0
Lb. murinus CRL 1695 0 0 0 0 0 0 0 0
Lb. mucosae  CRL 1696 0 0 0 0 0 0 0 0










































-1 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 2,0,0 0,0,0 2,3,5 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0
-2 1,2,0 2,0,0 3,5,0 5,5,0 2,3,0 3,0,0 3,0,0 5,5,6 2,5,0 0,0,0 5,5,5 5,5,3 5,0,0 5,0,0 5,5,0 0,0,0 5,4,0
CRL 1421
-1 2,3,0 4,4,0 3,5,0 0,2,0 5,4,0 3,0,0 5,5,0 3,4,5 2,0,0 2,0,0 5,5,5 4,5,3 2,0,0 3,4,0 2,0,0 2,3,0 3,4,0
-2 2,0,0 2,3,2 2,3,0 2,4,0 4,4,0 5,4,0 5,5,0 5,5,6 5,5,0 5,5,5 5,3,6 5,5,6 5,0,0 5,3,3 5,3,2 5,5,3 5,5,5
CRL 1460
-1 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 3,2,0 5,5,6 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0
-2 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0
CRL 1461
-1 0,0,0 0,0,0 0,0,0 0,3,0 0,0,0 0,0,0 0,0,0 8,10,7 0,0,0 0,0,0 3,0,0 4,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0
-2 0,0,0 0,0,0 0,0,0 1,1,0 0,0,0 0,0,0 0,0,0 10,8,9 0,0,0 0,0,0 1,1,2 1,1,1 0,0,0 0,0,0 0,1,0 3,2,0 1,2,0
CRL 1574
-1 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 5,0,0 4,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0
-2 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 6,4,0 2,0,0 2,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0
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E. coli S. aureus E. faecium S. dysgalactiae S. agalactiae S.C.Negat S. bovis
Neut N.N Neut N.N Neut N.N Neut N.N Neut. N.N Neut N.N Neut N.N Neut N.N
Lb. plantarum  CRL 1716 5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
E. mundtii CRL 1656 9 11 0 0 0 0 7 8 5 4 0 0 0 0 0 0
W. cibaria CRL 1833 8 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
E. faecium CRL 1657 8 7 0 0 0 0 4 4 1 1 0 0 0 0 0 0
Lb. perolens CRL 1724 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Lc. lactis subsp lactis CRL 
1655
8 7 0 0 4 5 0 0 2 5 4 4 6 6 2 5
E. hirae CRL 1835 5 6 0 0 0 0 6 6 3 5 0 0 0 0 0 0
E. hirae CRL 1842 4 4 0 0 0 0 1 2 2 0 0 0 0 0 0 0
P. pentosaceus CRL 1831 5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Beneficial enzymes
As the strains under evaluation are planned to be included in 
a multi-strain formula, the evaluation of the beneficial enzymes 
produced were also of main interest. The enzymes screened 
were amylase, cellulose and xylanase supported by the possi-
bilities of administration to different aged animals. The adult 
cows are fed with different type of grains, where the three en-
zymes evaluated could exert some type of fiber-degradation. 
Amylase catalyzes the hydrolysis of 1-4 bonds of α-amylase, by 
digesting glycogen and starch to form simple sugars. When in-
corporated into the diet of ruminants, starch is degraded mainly 
by the amylolytic bacteria, which ferment the reserve carbohy-
drates (starch) present in grains. The digestibility of the starch 
in the rumen is high and the fraction that manages to pass to 
the intestine can be degraded by the pancreatic amylase of the 
animal and thus absorbed as glucose, which favors the rumi-
nant by providing a direct source of glucose. Hence the impor-
tance of isolating lactic bacteria with amylolytic properties as 
potential probiotics for ruminants, since they would favor the 
digestive process in diets with a high concentration of energy 
compounds, favoring weight gain. All the strains under study, 
independently of the isolation origin, were not able to produce 
xylanase, amylase and celullase enzymes under the conditions 
assayed.
Compatibility of the strains
The ideal formula to be applied in the three areas of bovines 
could be designed or formulated with one or two strains iso-
lated from each mucosal tract or ecosystem. When determining 
the compatibility of the selected strains (with beneficial charac-
tersitics), Lc. lactis subsp lactis CRL1655 (bacteriocin producer) 
can be combined only with Lb. fermentum CRL1575 and Lb. 
gasseri CRL1566, because inhibits all the other strains. It was 
observed that Lb. gasseri CRL1412 and CRL1421 were the most 
sensitive strains, since they were inhibited by most of the as-
sayed strains. The other strains show some type of inhibition 
only to specific strains, and in higher dilutions as shown in Table 
5. Then, a mixed probiotic formula can de designed or formu-
lated by combining most of the strains, except Lc. lactis subsp 
lactis CRL1655 that must be used individually. Although the use 
of probiotic products in animals formulated with a combination 
or multiple-strains is very frequent [58,59], the evaluation of 
the degree of interactions or compatibility between potentially 
probiotic LAB strains has not been reported to date, to be ap-
plied to different bovine ecosystems. In this assay, the lactoba-
cilli evaluated showed different spectra of inhibition between 
them. This study, therefore, allows the selection of compatible 
strains for their potential inclusion in a probiotic / pharmaco-
logical product.
Table 5: Compatibility between strains of Lactobacillus isolated from vagina and mammary gland of adult bovine females, and 
gastrointestinal tract of calves
4b
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CRL 1575
-1 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0
-2 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 3,0,0 3,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0
CRL 1566
-1 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 5,0,0 3,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0
-2 0,0,0 0,0,0 1,4,0 0,0,0 5,0,0 4,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0
CRL 1655
-1 0,0,0 2,0,0 2,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0
-2 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 2,0,0 3,0,0 0,0,0 0,0,0 1,0,0 1,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0
CRL 1716
-1 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 1,1,2 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0
-2 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 5,4,7 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0
CRL 1724
-1 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 5,2,1 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0
-2 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 8,5,3 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0
CRL 1831
-1 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 4,4,2 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0
-2 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 6,3,2 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0
CRL 1833
-1 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 10,6,3 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0
-2 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 6,4,2 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0
CRL 1842
-1 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 6,2,2 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0
-2 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 6,3,2 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0
CRL 1693
-1 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 7,3,2 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0
-2 0,0,0 0,0,0 0,0,0 0,0,0 2,2,1 2,0,0 2,0,0 10,6,5 3,3,3 3,2,0 4,0,0 3,0,0 2,2,2 0,0,0 0,0,0 0,0,0 0,0,0
CRL 1695
-1 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 6,3,2 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0
-2 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 10,4,2 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0
CRL 1696 -1 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 10,3,1 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0
-2 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 1,2,0 5,4,3 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0
CRL 1702 -1 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 10,6,4 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0
-2 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 6,3,2 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0 0,0,0
aVaginal and mammary gland lactobacilli from adult bovine female and gastrointestinal tract of calves used as indicator (sensitive) strains of in-
hibitory substances produced by Lactobacilli.
bVaginal and mammary gland lactobacilli from adult bovine female and gastrointestinal tract of calves used as inhibitory substances producers 
against Lactobacilli. 
The results represent the size of the inhibition halos (in mm) produced by the Lactobacillus supernatant (untreated, neutralized and neutralized 
and treated with catalase).
Table 6: Homologous beneficial LAB strains selected by their probiotic characteristics for the design of a cattle formula  
Strain Origin
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0 72 1,48 0,73 0,28 0,01 17,1710 5,500 1 0,27 n.d
Lb. gasseri CRL 
1421
0 64 1,37 0,81 0,19 0,16 - - 0,27 n.d
Lb. gasseri CRL 
1460





0,60 0 0,41 - - 0,12 n.d
P. pentosaceus 




0,73 0,05 0,13  4,500 5,500 -
n.d
0,20
W. cibaria CRL 
1833









0,17 0,25 0,21 - 5 0 6.38
Lb. mucosae 
CRL1696





0 0,15 0,31 - 5 0,37 8.12
specific incidence rate of clinical mastitis, test-day somatic cell 
count, and test-day milk yield. J Dairy Sci. 2014; 97: 7927-7939
12. Cheng J, Palva AM, de Vos WM, Satokari R. Contribution of the 
intestinal microbiota to human health: from birth to 100 years 
of age. Curr Top Microbiol Immunol. 2013; 358: 323-346.
13. Douillard FP, de Vos W. Functional genomics of lactic acid bacte-
ria: from food to health. Microb Cell Fact. 2014.
14. Eren AM, Sogin ML, Morrison HG, Vineis JH, Fisher JC, et al. A 
single genus in the gut microbiome reflects host preference and 
specificity. ISME J. 2004; 9: 90-100. 
15. Armas F, Camperino C, Marianelli C. In Vitro Assessment of 
the Probiotic Potential of Lactococcus lactis LMG 7930 against 
Ruminant Mastitis-Causing Pathogens. PLoS One. 2017; 9; 12: 
e0169543.  
16. Pellegrino M, Berardo N, Giraudo J, Nader-Macías MEF, Bogni 
C. Bovine mastitis prevention: humoral and cellular response of 
dairy cows inoculated with lactic acid bacteria at the dry-off pe-
riod. Benef Microbes. 2017; 8: 589-596.
17. Shiva C, Arosemena Angulo EL, Calvo MA. Organic acids as a pos-
sible alternative to probiotics. Rev Albeitar. 2017; 209: 4-14. 
18. FAO/WHO .2001.
19. ISAPP (International Scientific Association for Probiotics and 
Prebiotics) Prebiotics: A Consumer Guide for Making Smart 
Choices. 2009.
20. Hill C, Guarner F, Reid G, Gibson GR, Merenstein DJ, et al. The 
International Scientific Association for Probiotics and Prebiotics 
consensus statement on the scope and appropriate use of the 
term probiotic. Nat Rev Gastroenterol Hepatol. 2015.
21. Genís S, Bach À, Fàbregas F, Arís A. Potential of lactic acid bac-
teria at regulating Escherichia coli infection and inflammation of 
bovine endometrium. Theriogenology. 2016; 85: 625-637. 
22. Genís S, Bach À, Arís A. Effects of intravaginal lactic acid bacteria 
on bovine endometrium: Implications in uterine health. Veteri-
nary Microbiology. 2017; 204: 174-179.  
23. Genís S, Cerri RLA, Bach À, Silper BF, Baylão M, et al. Pre-calv-
ing Intravaginal Administration of Lactic Acid Bacteria Reduces 
Metritis Prevalence and Regulates Blood Neutrophil Gene Ex-
pression After Calving in Dairy Cattle. Front Vet Sci. 2018; 21; 
5:135. 
24. Pellegrino M, Frola ID, Berardo N, Gobelli D, Nader-Macias MEF, 
et al. In Vitro Characterization of Lactic Acid Bacteria Isolated 
from Bovine Milk as Potential Probiotic Strains to Prevent Bo-
vine Mastitis. Probiotics Antimicrob Proteins. 2018.
25. Maldonado NC, Chiaraviglio J, Bru E, De Chazal L, Santos V, et 
al. Effect of Milk Fermented with Lactic Acid Bacteria on Diar-
rheal Incidence, Growth Performance and Microbiological and 
Blood Profiles of Newborn Dairy Calves. Probiotics Antimicrob 
Proteins. 2017; 10: 668-676. 
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MRS-T, LAPTg-T: culture medium without Tween 80; MRSg: culture medium enriched with glucose 10%; MRSs: MRS enriched with sucrose 10%; 
1: L. monocytogenes FBUNT; 2: E. coli ATCC12900; 3: S. dublin MP/07; 4: S. aureus FBUNT; 5: S. typhimurium MP/08. N.d: undetermined.
a Autoaggregative capability (Ocaña and Nader-Macias, 2002).
b Determined by MATH in hexadecane (Otero et al, 2004).
c Determined by technique of quantification of biofilm in polystyrene microplates modified (Leccese Terraf et al., 2016). 
d Technique described by Quesada et al, 1993 / Gómez, 2005.
e Analyzed by the plate diffusion method described by Ocaña et al, 1999 and Juárez Tomás et al, 2004.
f Determined by spectrophotometric method of o-dianisidine and peroxidase (Juarez Tomas et al, 2004).
g The lactic acid production was obtained by HPLC in a 16 h culture in LAPTg broth (Maldonado et al, 2012).
Conclusions
The results obtained allow to go further in the design of a 
homologous, host-specific multi-strain probiotic formula to be 
applied at different tracts in cattle. From 38 LAB strains with 
potential probiotic properties, only 10 strains showed to share 
properties or to express different beneficial characteristics were 
selected, in such a way to complement their effect. Table 6 
shows the compatible strains with beneficial properties, hat will 
be further evaluated in their technological characteristics. 
Acknowledgements
This work was supported by PICT 2017-4324 and 1187 (FON-
CYT-MINCYT) and PIP 744 and 545 from CONICET (Consejo Na-
cional de Investigaciones Científicas y Técnicas, Argentina). 
References 
1. Quigley EM. Basic Definitions and Concepts: Organization of the 
Gut Microbiome. Gastroenterol Clin North Am. 2017; 46: 1-8. 
2. Ma T, Suzuki Y, Guan LL. Dissect the mode of action of probiot-
ics in affecting host-microbial interactions and immunity in food 
producing animals. Vet Immunol Immunopathol. 2018; 205: 35-
48.  
3. Bleich A, Fox JG. The Mammalian Microbiome and Its Impor-
tance in Laboratory Animal Research. ILAR J. 2015; 56: 153-158.
4. Mendes R, Raaijmakers JM. Cross-kingdom similarities in micro-
biome functions. ISME J. 2015; 9: 1905-1907. 
5. Li K, Bihan M, Methéet BA. Analyses of the stability and core 
taxonomic memberships of the human microbiome. PLoS One. 
2013; 6; 8: e63139.
6. Stumpf RM, Wilson BA, Rivera A, Yildirim S, Yeoman CJ, et al. The 
primate vaginal microbiome: comparative context and implica-
tions for human health and disease. Am J Phys Anthropol. 2013; 
152: 119-134.
7. Kleerebezem M, Vaughan EE. Probiotic and gut lactobacilli and 
bifidobacteria: molecular approaches to study diversity and ac-
tivity. Annu Rev Microbiol. 2009; 63: 269-290.
8. Nader Macías MEF, Otero MC, Espeche MC, Maldonado NC. Ad-
vances in the design of probiotic products for the prevention of 
major diseases in dairy cattle. J Ind Microbiol Biotechnol. 2008; 
35: 1387-1395.  
9. Clempson AM, Pollott GE, Brickell JS, Wathes DC. Associations 
between bovine IGFBP2 polymorphisms with fertility, milk pro-
duction, and metabolic status in UK dairy cows. Anim Biotech-
nol. 2012; 23: 101-113.
10. Reverter A, Fortes MR. Breeding and Genetics Symposium: 
building single nucleotide polymorphism-derived gene regula-
tory networks: Towards functional genomewide association 
studies. J Anim Sci. 2013; 91: 530-536.
11. Verbeke J, Van Poucke M, Peelman L, Piepers S, De Vliegher S. 
Associations between CXCR1 polymorphisms and pathogen-
MedDocs Publishers
11Journal of Veterinary Medicine and Animal Sciences
26. Maldonado NC, Ficoseco Aristimuño C, Mansilla FI, Melián C, 
Hebert E, et al. Identification, characterization and selection of 
autochthonous lactic acid bacteria as probiotic for feedlot cattle. 
Livestock science. 2018; 212: 99-110.
27. Otero MC, Nader Macías MEF. Inhibition of Staphylococcus au-
reus by H2O2-producing Lactobacillus gasseri isolated from the 
vaginal tract of cattle. Anim Reprod Sci. 2006; 96: 35-46.
28. Espeche C, Pellegrino M, Frola I, Larriestrac A, Bogni C, et al. Lac-
tic acid bacteria from raw milk as potentially beneficial strains to 
prevent bovine mastitis. Anaerobe. 2012; 18: 103-109.  
29. Aristimuño Ficoseco C, Mansilla I, Maldonado N, Miranda H, 
Nader Macias F, et al. Safety and Growth Optimization of Lactic 
Acid Bacteria Isolated from Feedlot Cattle for Probiotic Formula 
Design. Front Microbiol. 2018; 9: 2220.
30. Frola ID, Pellegrino MS, Espeche MC, Giraudo JA, Nader-Macias 
ME, et al. Effects of intramammary inoculation of Lactobacillus 
perolens CRL1724 in lactating cows’ udders. J Dairy Res. 2012; 
79: 84-92.
31. Frola ID, Pellegrino MS, Magnano G, Giraudo JA, Espeche MC, 
et al.  Histological examination of non-lactating bovine udders 
inoculated with Lactobacillus perolens CRL 1724. J Dairy Res. 
2013; 80: 28-35. 
32. Otero MC, Morelli L, Nader Macías M.F. Probiotic properties of 
vaginal lactic acid bacteria to prevent metritis in cattle. Lett Appl 
Microbiol. 2006; 43: 91-97.
33. Otero MC, Ocaña VS, Nader-Macías MEF. Bacterial surface char-
acteristics applied to selection of probiotic microorganisms. 
Public Health Microbiology: Methods and Protocols. Methods in 
Molecular Biology. 2004; 268: 435-440.
34. Rosenberg M, Doyle RJ. Microbial cell surface hydrophobicity: 
history, measurement, and significance. Microbial Cell Surface 
Hydrophobicity. 1990; 1-37.
35. Ocaña V, de Ruiz Holgado AA, Nader-Macías MEF. Characteriza-
tion of a bacteriocin-like substance produced by a vaginal Lac-
tobacillus salivarius Strain. Appl Environ Microbiol. 1999; 65: 
5631-5635.
36. Ocaña VS, de Ruiz Holgado AA, Nader-Macías MEF. Growth inhi-
bition of Staphylococcus aureus by H2O2-producing Lactobacil-
lus paracasei subsp. paracasei isolated from the human vagina. 
FEMS Immunol Med Microbiol. 1999; 23: 87-92.
37. Ocaña VS, de Ruiz Holgado AA, Nader-Macías MEF. Selection of 
vaginal H2O2-generating Lactobacillus species for probiotic use. 
Curr Microbiol. 1999; 38: 279-84.
38. Vandervoorde L, Christiaens H, Verstraete W. Prevalence of co-
aggregation among chicken lactobacilli. J Appl Bacteriol. 1992; 
72: 214-219.
39. Ocaña VS, Nader-Macías MEF. Vaginal lactobacilli: self and co-
aggregation. Br J Biomed Sci. 2003; 59: 183-190.
40. O’Toole GA, Kolter R. Flagellar and twitching motility are nec-
essary for Pseudomonas aeruginosa biofilm development. Mol 
Microbiol. 1998; 30: 295-304.
41. Lebeer S, Ceuppens J, Geboes K, Van Assche G, Rutgeerts P, et 
al. Mechanisms of probiotic-host interaction with IBD as a case 
study: ¿a role for exopolysaccharides? Commun Agric Appl Biol 
Sci. 2007; 72: 41-45.
42. Lebeer S, Verhoeven LA, Perea Vélez M, Vanderleyden J, De 
Keersmaecker S. Impact of environmental and genetic factors 
on biofilm formation by the probiotic strain Lactobacillus rham-
nosus GG. Appl Environ Microbiol. 2007; 73: 6768-6775. 
43. Leccese Terraf MC, Juárez Tomás MS, Rault L, Le Loir Y, Even S, et 
al. Biofilms of vaginal Lactobacillus reuteri CRL 1324 and Lacto-
bacillus rhamnosus CRL 1332: kinetics of formation and matrix 
characterization. Arch Microbiol. 2016; 198: 689-700. 
44. Van Geel-Schutten GH, Flesch F, ten Brink B, Smith MR, Dijkhui-
zen L. Screening and characterization of Lactobacillus strains 
producing large amounts of exopolysaccharides. Appl Micro-
biol Biotechnol. 1998.
45. Quesada E, Bejar V, Calvo C. Exoplysaccharide production by 
Volcaniella eurihalina. Experentia. 1993; 49: 1037-1041.
46. Juárez Tomás MS, Ocaña VS, Wiese B, Nader-Macías ME. Growth 
and lactic acid production by vaginal Lactobacillus acidophilus 
CRL 1259, and inhibition of uropathogenic Escherichia coli. J 
Med Microbiol. 2004; 52: 1117-1124.
47. Jack RW, Tagg JR, Ray B. Bacteriocins of Gram-positive bacteria. 
Microbiol. Rev. 1995; 59: 171-200. 
48. Ocaña VS, Bru E, De Ruiz Holgado AA, Nader-Macias MEF. Sur-
face characteristics of lactobacilli isolated from human vagina. J 
Appl Microbiol. 1999; 45: 203-212.
49. Juárez Tomás MS, Bru E, Nader-Macías ME. Comparison of the 
growth and hydrogen peroxide production by vaginal probiotic 
lactobacilli under different culture conditions. Am J Obstet Gy-
necol. 2003; 188: 35-44.
50. Maldonado J, Cañabate F, Sempere L, Vela F, Sánchez AR, et al. 
Human milk probiotic Lactobacillus fermentum CECT5716 re-
duces the incidence of gastrointestinal and upper respiratory 
tract infections in infants. J Pediatr Gastroenterol Nutr. 2012; 54: 
55-61. 
51. De Gregorio E, Rappuoli R. From empiricism to rational design: 
a personal perspective of the evolution of vaccine development. 
Nat Rev Immunol. 2014; 14: 505-514.
52. Chabot S, Yu HL, de Léséleuc L, Cloutier D, van Calsteren MR, 
et al. Exopolysaccharides from Lactobacillus rhamnosus RW-
9595M stimulate TNF, IL-6 and IL-12 in human and mouse cul-
tured immunocompetent cells, and IFN-γ in mouse splenocytes. 
INRA Editions. 2001; 81: 683-697. 
53. Ruas-Madiedo P, de los Reyes-Gavilán CG. Invited Review: Meth-
ods for the Screening, Isolation, and Characterization of Exopoly-
saccharides Produced by Lactic Acid Bacteria. J. Dairy Sci. 2015; 
88: 843-856.
54. Cerning J, Renard CM, Thibault JF, Bouillanne C, Landon M, et al. 
Carbon Source Requirements for Exopolysaccharide Production 
by Lactobacillus casei CG11 and Partial Structure Analysis of the 
Polymer. Appl Environ Microbiol. 1994; 60: 3914-3919.
55. Mozzi F, Rollán G, de Giori GS, Font de Valdez G. Effect of galac-
tose and glucose on the exopolysaccharide production and the 
activities of biosynthetic enzymes in Lactobacillus casei CRL 87. 
J Appl Microbiol. 2001; 91: 160-167.
56. Mokoena MP. Lactic Acid Bacteria and Their Bacteriocins: Clas-
sification, Biosynthesis and Applications against Uropathogens: 
A Mini-Review. Molecules.2017; 22. 
57. Parada JL, Ricoy Caron C, Bianchi P, Medeiros A, Soccol CR.  Bac-
teriocins from lactic acid bacteria: Purification, properties and 
use as biopreservatives. Braz. Arch. Biol. Technol. 2007; 50: 521-
542.
58. MacPhee RA, Hummelen R, Bisanz JE, Miller WL, Reid G. Pro-
biotic strategies for the treatment and prevention of bacterial 
vaginosis. Expert Opin Pharmacother. 2010; 11: 2985-2995.
59. Salminen S, Nybom S, Meriluoto J, Collado MC, Vesterlund S, et 
al. Interaction of probiotics and pathogens-benefits to human 
health? Curr Opin Biotechnol. 2010; 21: 157-167. 
60. Juárez Tomás MS, Nader Macías MEF. Communicating Current 
Research and Educational Topics and Trends in Applied Microbi-
ology. Microbiology Book Series. Ed.: Méndez-Vilas A. Formatex. 
2007; 732-739.
MedDocs Publishers
12Journal of Veterinary Medicine and Animal Sciences
